Free Daily Analysis

Stock Trend Analysis Report

Prepared for you on Monday, October 25, 2021.

Loncar Cancer Immunotherapy ETF (NASDAQ:CNCR)

Strong Downtrend (-100) - CNCR is in a strong downtrend that is likely to continue. With short-term, intermediate, and long-term bearish momentum, SHORTSYMBOL continues to fall. Traders should use caution and set stops.

Is it time to buy, sell, or avoid CNCR?

MarketClub looks at technical strength and momentum to determine if the timing is right for CNCR.

Learn more about the Trade Triangles and how we make technical analysis as easy as buy and sell.

Open High Low CNCR Price Change
29.0700 29.0001 28.8900 28.8900 +0.1512
Entry Signal

MarketClub’s Trade Triangles for CNCR

long term down The long-term trend has been DOWN since Aug 17th, 2021 at 28.1200

intermediate term down The intermediate-term trend has been DOWN since Sep 20th, 2021 at 30.1699

short term down The short-term trend has been DOWN since Sep 24th, 2021 at 30.9300

Smart Scan Analysis for CNCR

Based on our trend formula, CNCR is rated as a -100 on a scale from -100 (Strong Downtrend) to +100 (Strong Uptrend).

Smart Scan Analysis for CNCR
Strong Downtrend Sideways Strong Uptrend
Open High Low Price Change
29.0700 29.0001 28.8900 28.8900 +0.1512
Prev. Close Volume Bid Ask Time
28.7388 423 2021-10-25 12:13:58
Year High32.32Year High Date2018-03-13
Year Low19.1252Year Low Date2018-10-29
52wk High35.81852wk High Date2021-02-08
52wk Low26.1752wk Low Date2020-10-30
Average Volume6,008Shares Outstanding100
Market Cap34MVolatility39.81
Get a free daily analysis and signals for Loncar Cancer Immunotherapy ETF (CNCR) - Request Your Free Report.